This ontology is distributed under a Creative Commons Attribution License - http://creativecommons.org/licenses/by/4.0/
The Guide to Pharmacoloty Ontoloty (GTPO) is used to define the entities which appear in the Guide to Pharmacology RDF representation. It is based on the Guide to Pharmacology glossary of terms.
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Action
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ActivationAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ActivatorInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AgonistInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AllostericModulatorInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotatedAwaitingReview
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotatedExpertReviewed
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotationStatus
Class describing annotation status of targets, defined by Guide to Pharmacology
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntagonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntagonistInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntibodyInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntibodyLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BiasedAgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BindingAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BiphasicAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#CatalyticReceptorTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ChannelBlockerInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#CompetitiveAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#EnzymeTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#FeedbackInhibitionAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#FullAgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GProteinCoupledReceptorTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GatingInhibitorInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GroupingTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InhibitionAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InhibitorInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InorganicLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Interaction
Class describing the interactions between chemicals and proteins stored in the Guide to Pharmacology data
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InverseAgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#IrreversibleAgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#IrreversibleInhibitionAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Ligand
Class describing the chemicals stored in the Guide to Pharmacology data
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#LigandGatedIonChannelTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#LigandTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#MetaboliteLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#MixedAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NaturalProductLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NegativeAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NeutralAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NoAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NonCompetitiveAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NuclearHormoneReceptorTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#OtherIonChannelTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#OtherProteinTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PartialAgonistAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PeptideLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PoreBlockerAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PositiveAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PotentiationAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SlowsInactivationAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SubunitSpecificInteraction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SyntheticOrganicLigand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Target
Class describing the different proteins stored in the Guide to Pharmacology data
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#TargetFamily
Class describing families of proteins stored in the Guide to Pharmacology data
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#TransporterTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#UnderDevelopment
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Unknown
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#VoltageDependentInbibitionAction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#VoltageGatedIonChannelTargetFamily
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAction
Action of an interaction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAffinity
Reference to a node describing interaction affinity values and units
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAnnotationStatus
Annotation status of a given target
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasLigand
ligand participant of an interaction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasRef
Reference to Blank node pair, containing cross reference and taxonomy
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasReference
Reference to PubMed id of article describing interaction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasSpecies
Cross reference to NCBI taxonomy
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasTarget
target participant of an interaction
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasTargetFamily
target family of a target
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasUnit
Cross reference to unit description from BAO ontology
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#xref
Cross reference to external database
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#approved
Approval status of a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#canonicalSMILES
canonical SMILES, describing a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#comment
Guide to Pharmacology comments on a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasHighValue
High value of an interaction affinity, also has low value
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasLowValue
Low value of an interaction affinity, also has high value
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasMedianValue
Median value of an interaction affinity
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InChIID
InChI identifier for a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InChIKEY
InChI key defining a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#isomericSMILES
isomeric SMILES, describing a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#iupacName
name of a ligand, defined by the IUPAC
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ligandName
the name of a chemical ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#nomenclature
nomenclature, the name of a target
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#synonym
Synony of a ligand
IRI: http://rdf.guidetopharmacology.org/ns/gtpo#targetFamilyName
name for target family
antibody interactionc, inorganic ligandc, metabolite ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc
This HTML document was obtained by processing the OWL ontology source code through LODE, Live OWL Documentation Environment, developed by Silvio Peroni.
Class describing different interaction actions, defined by Guide to Pharmacology